WEE1 and neoplasm: The immunohistochemical staining indicated a significant decrease in Wee1 expression in tumours treated with in vivo‐ready mirVanaTM miR‐15b mimics and in tumours established with KHOSMR cells previously transfected with miR‐15b precursor (Fig. 5C).